Marc Abrams
Chief Technology Officer SanegeneBio
Seminars
Friday 29th January 2027
Pioneering Advancements to Push Boundaries in Patient Care
10:00 am
- Explore the technologies emerging after the first wave of RNAi success
- Assess opportunities to further improve potency and durability
- Extend the commercial and clinical impact of tissue selective RNAi therapeutics
